Clinical Trial Update: MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating MYREPTIC-N and MY-REPT in stable kidney transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant

Drugs mentioned

• MY-REPT
• MYREPTIC-N

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Kidney Transplant | Phase 4 | Status: COMPLETED